Evidence map›Paper›PMID 38343887›Full record

ReviewFrontiers in cellular and infection microbiology2024

Effects of

Veronika Engelsberger, Markus Gerhard, Raquel Mejías-Luque

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
37.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Worldwide research trends on theFrontiers in immunology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. AdjuvantMicrobiology spectrum · 2026
    Trial
  5. Article
  6. Sex-Specific Associations ofThe world journal of men's health · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Beyond the Stomach: Exploring the Role ofExpert reviews in molecular medicine · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Veronika EngelsbergerInstitute for Medical Microbiology, Immunology and Hygiene, TUM School of Medicine and Health, Department Preclinical Medicine, Technical University of Munich, Munich, Germany.
Markus GerhardInstitute for Medical Microbiology, Immunology and Hygiene, TUM School of Medicine and Health, Department Preclinical Medicine, Technical University of Munich, Munich, Germany.
Raquel Mejías-LuqueInstitute for Medical Microbiology, Immunology and Hygiene, TUM School of Medicine and Health, Department Preclinical Medicine, Technical University of Munich, Munich, Germany.
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infecting about half of the world´s population,

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsHumansStomachAnti-Bacterial Agentsantibioticscolorectal cancereradication therapyHelicobacter pyloriimmune responseintestinal microbiome

Identifiers

PMID38343887
PMCPMC10853882
OpenAlexW4391262824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.